在急性冠状动脉综合征的护理和预后中存在与性别相关的差异
Csaba Sári1,2, Christian M Heesch1, Attila János Kovács1
1Gottsegen György National Cardiovascular Center, Budapest, Hungary.
Preventive medicine reports
|June 23, 2025
概括
在急性冠状动脉综合征 (ACS) 预后中存在性别差异. 虽然女性面临更高的短期死亡率,但他们显示出更好的长期预后,表明需要量身定制的,年龄调整的护理.
科学领域:
- 心脏病学 心脏病学
- 临床研究 临床研究
- 医学中的性别差异.
背景情况:
- 急性冠状动脉综合征 (ACS) 影响全球数以百万计的人,性别之间的结果各不相同.
- 了解性别特异性预后因素对于有效的心血管疾病管理至关重要.
研究的目的:
- 调查急性冠状动脉综合征 (ACS) 预后的性别差异.
- 分析所有原因死亡率,风险因素和男性和女性ACS患者之间的治疗结果的变化.
主要方法:
- 来自匈牙利国家心肌梗塞登记册 (2014-2019) 的76,153名患者的回顾性分析 (2014-2019).
- 主要结局:全因死亡率,平均随访时间为3.6年.
- 风险概况,治疗,并发症和性别之间的准则遵守,与年龄调整和多变量分析进行比较.
主要成果:
- 女性ACS患者年龄较大,心血管风险概况较差,接受治疗不太理想,并经历了更多的并发症.
- 未调整的死亡率在女性中较高;然而,多变量分析显示,与男性相比,女性的短期预后更差,但长期预后更好.
- 年龄显著影响了风险概况,ACS类型,治疗策略和结果.
结论:
- 在ACS预后中存在显著的性别差异,需要量身定制,根据年龄调整的治疗策略.
- 解决女性患者较高的死亡率需要了解她们的高级心血管风险概况和护理障碍.
- 公平获得及时和适当的护理对于改善所有ACS患者的结果至关重要,考虑到年龄,性别和并发症的相互作用.
更多相关视频
10:44Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
Published on: December 9, 2013
12.1K
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.4K
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
01:28Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
52
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
52
01:26Acute Coronary Syndrome V: Nursing Management
46
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
46
01:30Acute Coronary Syndrome I: Introduction
81
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
81
01:27Coronary Artery Disease V: Interprofessional Care
39
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39